Bitter melon extract (Insumate®)
Product description
Insumate® bitter melon extract contains the patented amino peptide sequence mcIRBP-19, which is a scientific-recognized active compound for glucose modulation. The clinical efficacy of Insumate® has been validated by two officially clinical studies. It is easy to be absorbed by human body due to the low molecular weight of mcIRBP-19. The underlying mechanism of glucose modulation has been verified by in-vitro and animal models.
Insumate® (NDIN No. 1256) is the first USFDA-approved bitter melon product.
Insumate® is produced by a unique fabrication process at low temperatures to ensure the product quality and remain the activity of mcIRBP-19. Currently, Greenyn is the only provider and ODM for Insumate®-associated products.
Read more
Insumate® (NDIN No. 1256) is the first USFDA-approved bitter melon product.
Insumate® is produced by a unique fabrication process at low temperatures to ensure the product quality and remain the activity of mcIRBP-19. Currently, Greenyn is the only provider and ODM for Insumate®-associated products.
Specifications
Categories | Botanical Extracts; Food Supplements / Nutraceuticals; Functional Food |
---|---|
Sales markets | Asia; North America |
Supplied from | Taiwan, China |
Product Applications | Dietary Supplements; Food Supplements; Natural And Traditional Remedies; Personal Care |
Product Certifications | Halal; Health & Safety (GMP, HAACP and equivalents); Quality assurance |
More products from Greenyn Biotechnology CO., LTD.
Products from other suppliers
❮
❯
-
SOLUGEL collagen peptides
-
Calcium Vitamin C Effervescent 1000Mg Vitamin D B6 Tablet Vitamin C D3 Effervescent Tablets
-
Sinpharderm-Hc Cream
-
Fibregum™
-
JOHA®- Emulsifying salts for processed cheese
-
RIBOTIDE® (I+G)
-
GermanProt
-
Crispact® Stick packs
-
BC30 Probiotic
-
GLP-1 Probiotics - Akkermansia muciniphila AH39 & Lactobacillus casei CCFM419
Bitter melon extract (Insumate®)